Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorpheniramine for Midazolam Paradoxical Reaction in Endoscopy
NCT03940391Unknown
- Sponsor
- Seoul National University Hospital
- Start
- May 2019
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-blind trial of chlorpheniramine in paradoxical reaction, sponsored by Seoul National University Hospital. Primary endpoint: Occurrence of severe paradoxical reaction (>= level 3) at 1 day. Status: unknown.
02
Drugs
chlorpheniramine
03
Conditions
paradoxical reaction
Beyond the preview
Go deeper on NCT03940391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03940391.